Status:
RECRUITING
A Twenty-years' Experience in Pituitary Disease.
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Pituitary Adenoma
Pituitary Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Pituitary tumors represent a heterogeneous group of neoplasms by histotype. The pituitary adenomas are the most frequent heteroformation, among those affecting the pituitary gland, followed by meningi...
Eligibility Criteria
Inclusion
- Patients underwent surgery for pituitary tumors;
- pathology diagnosis of pituitary tumors;
- patients older then 18 years at diagnosis of pituitary tumors;
- 2 years follow-up;
Exclusion
- age lower then 18 years
- follow-up shorter than 2 years
Key Trial Info
Start Date :
March 10 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 30 2028
Estimated Enrollment :
1600 Patients enrolled
Trial Details
Trial ID
NCT06973824
Start Date
March 10 2025
End Date
April 30 2028
Last Update
May 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Gemelli IRCCS
Rome, IT, Italy, 00168